GEKTERNA:ATHEXGek Terna S.A. Analysis
Data as of 2026-06-13 - not real-time
€44.68
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gek Terna’s stock is trading at €44.68, hugging the 52‑week high of €44.84 and the calculated resistance level of €44.84. The 20‑day SMA (≈€42.20) sits well below the market price, while the 200‑day SMA (≈€30.46) signals a strong long‑term uptrend. Momentum indicators are bullish: the MACD line sits above its signal (0.88 vs 0.77) and the histogram is positive, and the RSI‑14 69.5 is edging into overbought territory. Daily volume is rising, supporting the price advance. However, the stock is only €3.8 above the nearest support at €39.16, leaving a modest downside cushion. The “Extreme Greed” sentiment on the Fear‑Greed Index (89.9) reflects market optimism but also suggests possible short‑term complacency.
On the valuation side, the trailing P/E 32.1 sits above the industry average of 30.6, and the current price exceeds the analyst consensus target of €41.1, indicating the stock may be overvalued. Margins are thin (gross 12 %, operating 8.6 %, profit 4 %) and the company carries a heavy debt load (Debt/Equity ≈ 299 %), which limits earnings upside. The dividend yield of 0.9 % is modest and, given a payout ratio of ~30 % and zero operating cash flow, the dividend’s sustainability is questionable. Volatility is high at 26 % over the past 30 days, while beta is low (≈0.25), implying market‑neutral price swings but heightened firm‑specific risk. Geographic exposure across Greece, the Balkans, the Middle East and North America adds a layer of geopolitical and currency risk. Considering the bullish technical backdrop but weak fundamentals, a cautious stance is warranted.
On the valuation side, the trailing P/E 32.1 sits above the industry average of 30.6, and the current price exceeds the analyst consensus target of €41.1, indicating the stock may be overvalued. Margins are thin (gross 12 %, operating 8.6 %, profit 4 %) and the company carries a heavy debt load (Debt/Equity ≈ 299 %), which limits earnings upside. The dividend yield of 0.9 % is modest and, given a payout ratio of ~30 % and zero operating cash flow, the dividend’s sustainability is questionable. Volatility is high at 26 % over the past 30 days, while beta is low (≈0.25), implying market‑neutral price swings but heightened firm‑specific risk. Geographic exposure across Greece, the Balkans, the Middle East and North America adds a layer of geopolitical and currency risk. Considering the bullish technical backdrop but weak fundamentals, a cautious stance is warranted.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume
- RSI approaching overbought levels
- Price near resistance with limited upside
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Valuation above analyst target
- High debt and thin margins
- Modest dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term infrastructure contracts
- Diversified geographic footprint
- Potential for debt reduction
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin3.96%
P/E Ratio32.1
Debt/Equity299.05
P/B Ratio2.3
Industry P/E30.6
Technical Analysis
TrendBullish
RSI69.5
Support€39.16
Resistance€44.84
MA 20€42.20
MA 50€40.72
MA 200€30.46
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Target Price€41.07
Upside/Downside-8.08%
GradeOvervalued
TypeValue
Dividend Yield0.91%
Risk Assessment
Beta0.25
Volatility26.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.